CXCR3+ Treg have been isolated from the TME of ovarian cancer and HCC (37); increased CXCR3+ Treg presence in the TME has been correlated to a blunted effector response, and HCC tumor recurrence following transplantation (38, 39). Here, CXCR3 is linked to hepatocellular carcinoma.